As of Apr 20
| -0.02 / -0.32%|
The 6 analysts offering 12-month price forecasts for GenMark Diagnostics Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 8.00. The median estimate represents a +79.15% increase from the last price of 6.14.
The current consensus among 8 polled investment analysts is to Buy stock in GenMark Diagnostics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.